{"text": "Plasmids", "event": "<extra_id_0> <extra_id_1>"}
{"text": "For cloning of an <extra_id_0> APOBEC3G <extra_id_2> Protein <extra_id_1> promoter - driven reporter plasmid , genomic DNA was prepared from the T cell line PM1 using the DNeasy Kit ( Qiagen ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The DNA sequence ranging from positions -959 to +66 relative to the identified transcription start was amplified via PCR using the primers 3Gprom1025 ( 5'-TGTGAACGCGTTGCTGCAGGCCATCTGGATGTATATG-3 ' ) and 3Gpromreverse ( 5'-ACAGCAGATCTAGGGACCTCTGATAAAGACAGG-3 ' ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "PCR reactions were performed with <extra_id_0> Pwo <extra_id_2> Protein <extra_id_1> DNA Polymerase ( Roche ) using the following cycle conditions : one cycle 94degreesC for 2 min ; 30 cycles 94degreesC for 30 s , 58degreesC for 60 s , 72degreesC for 60 s ; one cycle 72degreesC for 7 min .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The amplicon was ligated into the promoterless <extra_id_0> luciferase <extra_id_2> Protein <extra_id_1> reporter plasmid pGL3-Basic ( Promega ) via MluI and BglII restriction sites , which were introduced by the primers .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The resulting construct contained 1025 bp of the <extra_id_0> A3G <extra_id_2> Protein <extra_id_1> promoter and was designated pGL3-APOprom1025 .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Reporter plasmids containing shorter fragments of the <extra_id_0> APOBEC3G <extra_id_2> Protein <extra_id_1> promoter were constructed using pGL3-APOprom1025 as template and the following forward primers : for plasmid pGL3-APOprom502 ( containing sequence -436 / +66 ) : 3Gprom502 ( 5'-TGTGAACGCGTTCCATAACATGGGGACAAGA-3 ' ) ; for plasmid pGL3-APOprom225 ( containing sequence -159 / +66 ) : 3Gprom225 ( 5'-TGTGAACGCGTCGAGGGCAGGATCCGGGAGT-3 ' ) ; for plasmid pGL3-APOprom180 ( containing sequence -114 / +66 ) : 3Gprom180 ( 5'-TGTGAACGCGTTCTTGATGGTGGAGAGGAGG-3 ' ) ; for plasmid pGL3-APOprom150 ( containing sequence -84 / +66 ) : 3Gprom150 ( 5'-TGTGAACGCGTGCGGGACCACCAGGGGAGGGGCTT-3 ' ) ; for plasmid pGL3-APOprom120 ( containing sequence -54 / +66 ) : 3Gprom120 ( 5'-TGTGAACGCGTTGCTGGCTCAGCCTGGTGTG-3 ' ) ; for plasmid pGL3-APOprom60 ( containing sequence +7 / +66 ) : 3Gprom60 ( 5'-TGTGAACGCGTCCCTTTGCAATTGCCTTG-3 ' ) ; each in combination with the reverse primer 3Gpromreverse ( described above ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "PCR reactions were performed with <extra_id_0> Pfu <extra_id_2> Protein <extra_id_1> Ultra Hotstart ( Stratagene ) using the following cycle conditions : one cycle 94degreesC for 2 min ; 30 cycles 94degreesC for 45 s , 58degreesC for 45 s , 72degreesC for 60 s ; one cycle 72degreesC for 7 min .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "As for pGL3-APOprom1025 , MluI and BglII restriction sites were introduced via the primers and PCR products were ligated into pGL3-Basic ( Promega ) via these restriction sites .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "pGL3-APOprom180mut carries two point mutations ( bold ) and was generated using the primer 3GProm180mut ( 5'-TGTGAACGCGTTCTTGATGGTGGAGAGGAGGCTCCAGCTGTTCGGGACCACCAG-3 ' ) in combination with primer 3Gpromreverse .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "This PCR was performed with an annealing temperature of 65degreesC .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "pGL3promE1 ( containing nucleotides -114 / -85 ) and pGL3promE2 ( containing nucleotides -92 / -63 ) were constructed by annealing the following single-stranded oligonucleotides : 114_85Plus ( 5' - CGCGTTCTTGATGGTGGAGAGGAGGCTCCAGCTGGA-3 ' ) and 114_85Minus ( 5' - GATCTCCAGCTGGAGCCTCCTCTCCACCATCAAGAA-3 ' ) or 92-63Plus ( 5'-CGCGTCCAGCTGGGCGGGACCACCAGGGGAGGGGCA-3 ' ) and 92_63Minus ( 5'-GATCTGCCCCTCCCCTGGTGGTCCCGCCCAGCTGGA-3 ' ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "After annealing , the double-stranded oligonucleotides which contained the respective 30 bp of the <extra_id_0> APOBEC3G <extra_id_2> Protein <extra_id_1> promoter and sticky ends compatible with MluI and BglII restriction sites were ligated into the pGL3 - Promoter ( Promega ) vector .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The sequences of all constructed plasmids were verified by sequence analysis .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Nucleotide -219 of the cloned <extra_id_0> APOBEC3G <extra_id_2> Protein <extra_id_1> promoter differs from the sequence in the database ( GenBanktrade accession number DQ147772 ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "An A-to-C substitution is present at this position .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Numbering is relative to the major transcriptional start site we identified .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The reporter plasmids pGL3 - Control and phRG-TK were purchased from Promega .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "pGL2-CVX contains two repeats of the IFN - responsive GAS ( gamma activated sequence ) elements ( GATCTGGATTTAGAGTAATATGAAACTGAAAGTACTTCG ) of the <extra_id_0> guanylate-binding protein <extra_id_2> Protein <extra_id_1> ( <extra_id_0> GBP <extra_id_2> Protein <extra_id_1> ) gene in front of a CMV minimal promoter and was kindly provided by Ute Pagelow and Mario Koster from the Helmholtz-Zentrum fur Infektionsforschung .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Plasmid pNL4-3 ( NIBSC , UK ) contains the full-length HIV-1NL4-3 genome and has been described previously ( 34 ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "pcDNA3.1Vif was generously provided by Nathaniel R . Landau from the Salk Institute , La Jolla .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "It was generated by amplifying the <extra_id_0> Vif <extra_id_2> Protein <extra_id_1> gene from pNL4-3 and ligating it into the pcDNA3.1 vector via BamHI and XhoI restriction sites .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "A 3'-WPRE element was included into the XhoI site .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "pBS-kRSPA - <extra_id_0> Tat <extra_id_2> Protein <extra_id_1> HIV-1 ( NL4-3 ) was constructed by amplifying the two exons of <extra_id_0> Tat <extra_id_2> Protein <extra_id_1> via PCR reaction using the molecular clone pNL4-3 as template and the following primer sets : exon1 , 5UXho1HIV - <extra_id_0> Tat <extra_id_2> Protein <extra_id_1> 1Plus ( 5'-GCATGCTCGAGATGGAGCCAGTAGATCCTAG-3 ' ) and HIV - <extra_id_0> Tat <extra_id_2> Protein <extra_id_1> 1Minus ( 5'-TGCTTTGATAGAGAAGCTTGATG-3 ' ) ; exon2 , 15FHIV - <extra_id_0> Tat <extra_id_2> Protein <extra_id_1> 2Plus ( 5'-TTCTCTATCAAAGCAACCCACCTCCCAATCCCG-3 ' ) and 5USpe1HIV - <extra_id_0> Tat <extra_id_2> Protein <extra_id_1> 2Minus ( 5'-GACGTACTAGTCTATTCCTTCGGGCCTGTC-3 ' ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "XhoI and SpeI restriction sites were introduced via the primers .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The sense-primer of exon2 starts with a 15-mer which is homologous to the 3 ' end of exon1 and necessary for fusion of both exons .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "PCRs were performed with Expand High Fidelity PCR System ( Roche ) using the following conditions : one cycle 94degreesC for 3 min ; 35 cycles 94degreesC for 45 s , 55degreesC for 45 s , 68degreesC for 45 s ; one cycle 68degreesC for 7 min .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "For fusion of both exons , the following PCR conditions were applied : one cycle 94degreesC for 3 min ; 35 cycles 94degreesC for 45 s , 58degreesC for 45 s , 68degreesC for 60 s .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "After 10 cycles without primers , the sense-primer of exon1 and the antisense - primer of exon2 were added for the remaining cycles .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The resulting amplicon was ligated into the pBS-kRSPA vector ( 35 ) via XhoI and SpeI restriction sites .", "event": "<extra_id_0> <extra_id_1>"}
